Top

Journal of Neurology

Published in:

01-03-2021 | Lymphoma | Original Communication

Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes

Authors: Jisun Jeong, Sun Woong Kim, Duk Hyun Sung

Published in: Journal of Neurology | Issue 3/2021

Abstract

Objectives

Neurolymphomatosis (NL) is a disease characterized by the infiltration of malignant lymphocytes into the peripheral nervous system. We report clinical features, radiographic findings, modes of treatment, and outcomes of patients with NL.

Methods

We retrospectively investigated patients with NL. We extracted data, including clinical features, magnetic resolution imaging (MRI), ¹⁸F-fludeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scans, cerebrospinal fluid cytology findings, the results of electrodiagnostic studies, as well as patient treatments and outcomes.

Results

Ten NL patients were identified. All patients reported pain/paresthesia and weakness in the affected area. The MRI scans were abnormal in eight out of nine patients with an enhancement of the spinal nerve root, plexus, peripheral nerve trunk, and cranial nerve. The FDG PET/CT scans were positive in all patients. Radiculopathy or radiculoplexopathy was the most common electrodiagnostic finding. Neurological improvement was observed in only three patients. The condition of the nine patients who underwent multimodality treatments for cancer eventually deteriorated and the patients died.

Conclusions

NL should be considered in the differential diagnosis of any type of neuropathy in patients with lymphoma. Because it could be confused with other neuropathies in lymphoma and various musculoskeletal diseases, a high index of suspicion and familiarity with clinical manifestation of NL are key. FDG PET/CT was the most sensitive diagnostic imaging modality to detect relevant neural invasion. The root within the spinal neural foramen was the most frequently affected neural structure. Early diagnosis of this rare neurologic manifestation of lymphoma may improve treatment outcomes.

Viala K, Behin A, Maisonobe T, Leger JM, Stojkovic T, Davi F, Leblond V, Bouche P (2008) Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry 79:778–782. https://doi.org/10.1136/jnnp.2007.125930CrossRefPubMed

Lim AT, Clucas D, Khoo C, Parameswaran BK, Lau E (2016) Neurolymphomatosis: MRI and (18) FDG-PET features. J Med Imaging Radiat Oncol 60:92–95. https://doi.org/10.1111/1754-9485.12321CrossRefPubMed

Diaz-Arrastia R, Younger DS, Hair L, Inghirami G, Hays AP, Knowles DM, Odel JG, Fetell MR, Lovelace RE, Rowland LP (1992) Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology 42:1136–1141. https://doi.org/10.1212/wnl.42.6.1136CrossRefPubMed

Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH (2003) Neurolymphomatosis. Neuro Oncol 5:104–115. https://doi.org/10.1093/neuonc/nop021CrossRefPubMedPubMedCentral

Kamiya-Matsuoka C, Shroff S, Gildersleeve K, Hormozdi B, Manning JT, Woodman KH (2014) Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes. J Neurol Sci 343:144–148. https://doi.org/10.1016/j.jns.2014.05.058CrossRefPubMed

Gan HK, Azad A, Cher L, Mitchell PL (2010) Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro Oncol 12:212–215. https://doi.org/10.1093/neuonc/nop021CrossRefPubMed

Baehring JM, Batchelor TT (2012) Diagnosis and management of neurolymphomatosis. Cancer J 18:463–468. https://doi.org/10.1097/PPO.0b013e31826c5ad5CrossRefPubMed

Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, Kuittinen O, Chamberlain MC, Roth P, Nemets A, Shalom E, Ben-Yehuda D, Siegal T, International Primary CNSLCG (2010) Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115:5005–5011. https://doi.org/10.1182/blood-2009-12-258210CrossRefPubMedPubMedCentral

Byun JM, Kim KH, Kim M, Kim TM, Jeon YK, Park JH, Paik JH, Lee JM, Lee HY, Lee JS, Heo DS, Lee JO (2017) Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience. Leuk Lymphoma 58:2624–2632. https://doi.org/10.1080/10428194.2017.1312376CrossRefPubMed

10.

Hughes RA, Britton T, Richards M (1994) Effects of lymphoma on the peripheral nervous system. J R Soc Med 87:526–530PubMedPubMedCentral

11.

Jellinger K, Radiaszkiewicz T (1976) Involvement of the central nervous system in malignant lymphomas. Virchows Arch A Pathol Anat Histol 370:345–362. https://doi.org/10.1007/BF00445779CrossRefPubMed

12.

Lagarde S, Tabouret E, Matta M, Franques J, Attarian S, Pouget J, Maues De Paula A, Figarella-Branger D, Dory-Lautrec P, Chinot O, Barrie M (2014) Primary neurolymphomatosis diagnosis and treatment: a retrospective study. J Neurol Sci 342:178–181. https://doi.org/10.1016/j.jns.2014.04.030CrossRefPubMed

13.

Kinoshita H, Yamakado H, Kitano T, Kitamura A, Yamashita H, Miyamoto M, Hitomi T, Okada T, Nakamoto Y, Sawamoto N, Takaori-Kondo A, Takahashi R (2016) Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases. J Neurol 263:1719–1726. https://doi.org/10.1007/s00415-016-8190-4CrossRefPubMed

14.

Salm LP, Van der Hiel B, Stokkel MP (2012) Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun 33:907–916. https://doi.org/10.1097/MNM.0b013e3283561881CrossRefPubMed

15.

Matsue K, Hayama BY, Iwama K, Koyama T, Fujiwara H, Yamakura M, Takeuchi M, O'Uchi T (2011) High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer 117:4512–4521. https://doi.org/10.1002/cncr.26090CrossRefPubMed

16.

Davidson T, Kedmi M, Avigdor A, Komisar O, Chikman B, Lidar M, Goshen E, Tzila Zwas S, Ben-Haim S (2018) FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes. Leuk Lymphoma 59:348–356. https://doi.org/10.1080/10428194.2017.1352096CrossRefPubMed

17.

Canh NX, Tan NV, Tung TT, Son NT, Maurea S (2014) (18)F-FDG PET/CT in neurolymphomatosis: report of 3 cases. Asia Ocean J Nucl Med Biol 2:57–64PubMedPubMedCentral

18.

Descamps MJ, Barrett L, Groves M, Yung L, Birch R, Murray NM, Linch DC, Lunn MP, Reilly MM (2006) Primary sciatic nerve lymphoma: a case report and review of the literature. J Neurol Neurosurg Psychiatry 77:1087–1089. https://doi.org/10.1136/jnnp.2006.087577CrossRefPubMedPubMedCentral

19.

Weerasuriya A, Mizisin AP (2011) The blood–nerve barrier: structure and functional significance. Methods Mol Biol 686:149–173. https://doi.org/10.1007/978-1-60761-938-3_6CrossRefPubMed

20.

Kanamori M, Matsui H, Yudoh K (1995) Solitary T-cell lymphoma of the sciatic nerve: case report. Neurosurgery 36:1203–1205. https://doi.org/10.1227/00006123-199506000-00024CrossRefPubMed

21.

(1995) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-1995. A 75-year-old man with multiple cranial-nerve defects and weakness and pain in the extremities. N Engl J Med 332:730–737. https://doi.org/10.1056/NEJM199503163321108

22.

Zimmerman HM (1975) Malignant lymphomas of the nervous system. Acta Neuropathol Suppl Suppl 6:69–74. https://doi.org/10.1007/978-3-662-08456-4_11CrossRef

23.

Sapunar D, Kostic S, Banozic A, Puljak L (2012) Dorsal root ganglion—a potential new therapeutic target for neuropathic pain. J Pain Res 5:31–38. https://doi.org/10.2147/JPR.S26603CrossRefPubMedPubMedCentral

24.

Abram SE, Yi J, Fuchs A, Hogan QH (2006) Permeability of injured and intact peripheral nerves and dorsal root ganglia. Anesthesiology 105:146–153. https://doi.org/10.1097/00000542-200607000-00024CrossRefPubMed

25.

Olsson Y (1968) Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol 10:26–33. https://doi.org/10.1007/BF00690507CrossRefPubMed

26.

Malmgren LT, Olsson Y (1980) Differences between the peripheral and the central nervous system in permeability to sodium fluorescein. J Comp Neurol 191:103–107. https://doi.org/10.1002/cne.901910106CrossRefPubMed

27.

Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM (1992) Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 79:2432–2437CrossRef

Title: Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes
Authors: Jisun Jeong
Sun Woong Kim
Duk Hyun Sung
Publication date: 01-03-2021
Publisher: Springer Berlin Heidelberg
Keyword: Lymphoma
Published in: Journal of Neurology / Issue 3/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-10202-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes

Abstract

Objectives

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2021

Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis

Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

Correction to: Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research

CANVAS: a late onset ataxia due to biallelic intronic AAGGG expansions